Cytori Therapeutics reported $-5282000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Cerus CERS:US $ -8.32M 3.89M
Cytori Therapeutics CYTX:US $ -5.28M 1.17M
Dr.Reddys Laboratories DRRD:IN IR 14680M 4672M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Infinity Pharmaceuticals INFI:US $ -11.99M 0.45M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Sanofi SAN:FP € 2660M 305M
Sun Pharmaceuticals SUNP:IN IR 22848.4M 4246.9M
Teva Pharmaceutical TEVA:IT -1160000000 189M